Reverse genetic tools and novel models of henipavirus infection10/28/2022 - 09/30/2025 (Co-Investigator)
PI:
Elke Muhlberger, PhDBill and Melinda Gates Foundation
Characterization of a human-specific positive regulator of flavivirus infection04/12/2021 - 03/31/2024 (PI)
NIH/National Institute of Allergy & Infectious Diseases5K22AI144050-02
Defining the Impact of Per/Polyfluoroalkyl Substance Exposure on Susceptibility to SARS-CoV-2 Infection and Disease03/02/2021 - 02/29/2024 (Multi-PI)
PI:
Florian Douam, PhDNIH/National Institute of Environmental Health Sciences5R21ES032882-02
Evaluation of mRNA-based vaccine approaches against endemic coronaviruses12/07/2021 - 09/30/2023 (PI)
Moderna Therapeutics
Therapeutic effects of NAPc2 in SARS-CoV-2 infection of K18-hACE2 transgenic mice03/15/2021 - 03/31/2022 (Multi-PI)
PI:
Florian Douam, PhDARCA Biopharma, Inc.